BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36842874)

  • 1. Report of S100+ CD34+ spindle cell neoplasm with BRAF-KIAA1549 fusion in a metacarpal bone of an adult.
    Marasco S; Di Bella C; Slavin JL; McKelvie PA
    Pathology; 2023 Aug; 55(5):715-718. PubMed ID: 36842874
    [No Abstract]   [Full Text] [Related]  

  • 2. S100/CD34-Positive Spindle Cell Mesenchymal Neoplasm Harboring KIAA1549-BRAF Fusion.
    Paton DJW; Wong D; Amanuel B; Cheah K; Ardakani NM
    Am J Dermatopathol; 2021 Mar; 43(3):217-220. PubMed ID: 33464748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups.
    Kurani H; Gurav M; Shetty O; Chinnaswamy G; Moiyadi A; Gupta T; Jalali R; Epari S
    Childs Nerv Syst; 2019 Sep; 35(9):1525-1536. PubMed ID: 31321520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein.
    Subbiah V; Westin SN; Wang K; Araujo D; Wang WL; Miller VA; Ross JS; Stephens PJ; Palmer GA; Ali SM
    J Hematol Oncol; 2014 Jan; 7():8. PubMed ID: 24422672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis.
    Antonelli M; Badiali M; Moi L; Buttarelli FR; Baldi C; Massimino M; Sanson M; Giangaspero F
    Pediatr Blood Cancer; 2015 Apr; 62(4):724-7. PubMed ID: 25382612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas.
    Kumar A; Pathak P; Purkait S; Faruq M; Jha P; Mallick S; Suri V; Sharma MC; Suri A; Sarkar C
    Cancer Genet; 2015 Mar; 208(3):91-5. PubMed ID: 25794445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low-grade malignant soft tissue tumor with S100 and CD34 co-expression showing novel CDC42SE2-BRAF fusion with distinct features.
    Sheng SJ; Li JM; Zou YF; Peng XJ; Wang QY; Fang HS; Li X; Ding Y; Fan QH; Zhang ZH; Wei YZ; Gong QX
    Genes Chromosomes Cancer; 2020 Oct; 59(10):595-600. PubMed ID: 32447786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of KIAA1549-BRAF fusion status in a case of rosette-forming glioneuronal tumor of the fourth ventricle (RGNT).
    Gessi M; Waha A; Setty P; Waha A; Pietsch T
    Neuropathology; 2011 Dec; 31(6):654-7. PubMed ID: 21518014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas.
    Roth JJ; Santi M; Pollock AN; Harding BN; Rorke-Adams LB; Tooke LS; Biegel JA
    Brain Pathol; 2015 Mar; 25(2):182-92. PubMed ID: 25040262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.
    Tian Y; Rich BE; Vena N; Craig JM; Macconaill LE; Rajaram V; Goldman S; Taha H; Mahmoud M; Ozek M; Sav A; Longtine JA; Lindeman NI; Garraway LA; Ligon AH; Stiles CD; Santagata S; Chan JA; Kieran MW; Ligon KL
    J Mol Diagn; 2011 Nov; 13(6):669-77. PubMed ID: 21884820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT).
    Gessi M; Lambert SR; Lauriola L; Waha A; Collins VP; Pietsch T
    J Neurooncol; 2012 Oct; 110(1):21-5. PubMed ID: 22814862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System.
    Ryall S; Arnoldo A; Krishnatry R; Mistry M; Khor K; Sheth J; Ling C; Leung S; Zapotocky M; Guerreiro Stucklin A; Lassaletta A; Shago M; Tabori U; Hawkins CE
    J Neuropathol Exp Neurol; 2017 Jul; 76(7):562-570. PubMed ID: 28863456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.
    Selt F; Hohloch J; Hielscher T; Sahm F; Capper D; Korshunov A; Usta D; Brabetz S; Ridinger J; Ecker J; Oehme I; Gronych J; Marquardt V; Pauck D; Bächli H; Stiles CD; von Deimling A; Remke M; Schuhmann MU; Pfister SM; Brummer T; Jones DT; Witt O; Milde T
    Oncotarget; 2017 Feb; 8(7):11460-11479. PubMed ID: 28002790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
    Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss.
    Kim YH; Nonoguchi N; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Mariani L; Giangaspero F; Tanaka Y; Nakazato Y; Vital A; Mittelbronn M; Perry A; Ohgaki H
    Brain Pathol; 2012 Nov; 22(6):834-40. PubMed ID: 22568401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adults.
    Badiali M; Gleize V; Paris S; Moi L; Elhouadani S; Arcella A; Morace R; Antonelli M; Buttarelli FR; Figarella-Branger D; Kim YH; Ohgaki H; Mokhtari K; Sanson M; Giangaspero F
    Brain Pathol; 2012 Nov; 22(6):841-7. PubMed ID: 22591444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of patient-derived models from a metastatic pediatric diffuse leptomeningeal glioneuronal tumor with KIAA1549::BRAF fusion.
    Messiaen J; Claeys A; Shetty A; Spans L; Derweduwe M; Uyttebroeck A; Depreitere B; Vanden Bempt I; Sciot R; Ligon KL; Jones DTW; Jacobs SA; De Smet F
    Acta Neuropathol; 2022 Oct; 144(4):793-797. PubMed ID: 35925403
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
    Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
    Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.
    Roth JJ; Fierst TM; Waanders AJ; Yimei L; Biegel JA; Santi M
    J Neuropathol Exp Neurol; 2016 Apr; 75(4):306-15. PubMed ID: 26945035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.